The Respiratory Strategies in COVID-19; CPAP, High-flow, and Standard Care (RECOVERY-RS) trial has demonstrated that treating hospitalized COVID-19 patients who have acute respiratory failure with continuous positive airway ...
Aug 5, 2021
0
2
Back problems are among the most common causes of sick leave. Every year as many as one in 15 adults in Norway sees a doctor or physiotherapist due to lower back pain. Worldwide, back pain is the most common cause of disability.
Aug 2, 2021
1
444
(HealthDay)—The Biden administration has reversed a Trump policy that limited the size of fines that U.S. nursing homes could be slapped with for violating safety standards.
Jul 30, 2021
0
2
Children in Israel aged five to 11 at risk of serious health complications can be vaccinated against COVID-19 as of August 1, Israeli health officials said Wednesday.
Jul 28, 2021
0
64
A team of cardiologists at St. Michael's Hospital are the first in Ontario to implant a new type of implantable cardioverter defibrillator (ICD), giving patients more freedom to enjoy their daily activities and reduce visits ...
Jul 22, 2021
0
3
Despite a sharp reduction in out-of-pocket (OOP) costs for preventive care since the Affordable Care Act was enacted in 2010, patients are still receiving unexpected bills for preventive services that should be free, according ...
Jul 21, 2021
0
2
Combining chemotherapy and BRAF oncogene inhibitors is an effective strategy for fighting metastatic melanoma, the leading cause of death from skin cancer in the world. This has been demonstrated in a study by researchers ...
Jul 13, 2021
0
2
Electroconvulsive therapy (ECT) is a medically safe mental health intervention, according to a new study led by CAMH researcher Dr. Tyler Kaster as part of his doctoral studies at ICES and the University of Toronto. The study ...
Jul 12, 2021
0
1
A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumor cells, is well tolerated by patients and keeps them ...
Jul 11, 2021
0
4
(HealthDay)—Lutetium-177 (177Lu)-prostate-specific membrane antigen (PSMA)-617 radioligand therapy added to standard care is beneficial for patients with advanced PSMA-positive metastatic castration-resistant prostate cancer, ...
Jul 6, 2021
0
0
